150 Pokemon Powerpoint

Armodafinil - key patent, SPC and data exclusivity expiry (44 country coverage) Why

Pipeline Selector allows you to avoid hours of painstaking research carried out quickly gives you a clear picture of a single inn, including key patents, extensions and exclusivity expiration data for 44 countries ( 7 country coverage also available), the regulatory issues and key players. The report covers

Pipeline Selector Armodafinil
Armodafinil indications: excessive sleepiness associated with narcolepsy, obstructive sleep apnea / hyponea syndrome, shift work sleep disorder
Armodafinil innovator Cephalon (Nuvigil)

# include publications of key patents for 44 countries (see list below)
# Contains SPC protection for all states EU Member States plus the extension of patent term other countries
# exclusive data calculated on a country by country to country
# Summary of dosage forms, strengths, indications and active ingredient forms of the product brand
# DMF filings and Paragraph IV Litigation
alerts
# # holders of marketing authorizations in selected territories
# analysis risks of patent via graphical display of data from patents
# Hyper-linking to crucial patent documents and national registries, which enable data verification

Key Patent Indicator enables easy identification of key patent, SPC and the protection of expiry information data covering 44 countries, including details of an extension (SPC and national legislation) for 30 European countries, Australia, Israel, Japan and the United States. (Also available with coverage of 44 countries)

For more information, visit:
http://www.aarkstore.com/reports/Armodafinil-Key-patent-SPC-and-data- exclusivity-term country-to-44- cover - 91054.html

Releted report

Atovaquone - key patent, SPC and data exclusivity expiry (44 country coverage)
Azelastine - key patent, SPC and data exclusivity expiry (44 country coverage )
Barnidipine - key patent, SPC and data exclusivity expiry (44 country coverage)
Bevacizumab - key patent, SPC and data exclusivity expires (44 country coverage)
Bortezomib - Patent key, SPC and data exclusivity expiry (44 country coverage)
Brimonidine - key patent, SPC and data exclusivity in anticipation expiration (44 country coverage)
brinzolamide - key patent, SPC and data exclusivity expiry (44 country coverage)
Budesonide - key patent, SPC and data exclusivity expiry (44 country coverage)
Carprofen (IFP) - key patent, SPC and data exclusivity expiry (44 country coverage)
Caspofungin - key patent, SPC and data exclusivity expiry (44 country coverage)
Ceftiofur (IFP) - key patent, SPC and data exclusivity expiry (44 countries cover)
Celecoxib - key patent, SPC, and data exclusivity expiry (44
Cetuximab country coverage - key patent, SPC and data exclusivity expiry (44 country coverage)
ciprofloxacin - Key patent, SPC, and the exclusivity data expiry (44 country coverage)
Cyclosporine - key patent, SPC and data exclusivity expiry (44 country coverage)